Share on Facebook
Share on Twitter
Share on LinkedIn

For the second time in a week, a maker of Type 2 diabetes drug Metformin announced a recall because the drug might have too much NDMA, a substance that can cause cancer in certain amounts.

The FDA said it found too much NDMA (N-Nitrosodimethylamine) in seven lots of Amneal’s Pharmaceuticals Metformin Hydrochloride Extended Release 500 mg, 750 mg tablets. According to the Amneal-written, FDA-posted recall notice, the FDA recommended recalling those seven lots and Amneal decided to yank all unexpired lots on the market.

Read More